Home
Archive
Subscribe
The Renewal
Logo

iPSC


Twenty years. Seven patients. A conditional approval.

Twenty years. Seven patients. A conditional approval.

In March, Japan approved the world's first iPSC-derived therapies. Here is what the evidence behind that approval actually looks like.

May 7, 2026

•

6 min read

The sales appointment that costs $20,000

The sales appointment that costs $20,000

The treatments were not FDA-approved. The patients were not told. The financing was arranged before they left the building.

Apr 21, 2026

•

5 min read

They treated a fetus with stem cells

They treated a fetus with stem cells

The result was specific, limited, and more important than most headlines made it sound.

Apr 7, 2026

•

8 min read

Can young stem cells reverse aging?

Can young stem cells reverse aging?

What a Phase 2b trial actually showed, and what the headlines decided it meant.

Mar 31, 2026

•

8 min read

The stem cell basics nobody bothered to explain

The stem cell basics nobody bothered to explain

The word "stem cell" is doing a lot of work it was never designed to do.

Mar 30, 2026

•

8 min read

Japan Special: The world's first iPSC approvals and what they actually mean

Japan Special: The world's first iPSC approvals and what they actually mean

What "approved" actually means. And what it doesn't

Mar 25, 2026

•

8 min read

background

The Renewal

Real regenerative medicine news, explained honestly, in ten minutes a week.

NAVIGATE

STAY INFORMED

Join readers who want the truth about regenerative medicine.

© 2026 The Renewal.
Report abusePrivacy policyTerms of use
beehiivPowered by beehiiv